ISPOR - PDG62 CURRENT TREATMENT STATUS WITH PROPROTEIN CONVERTASE SUBTILISIN-KEXIN TYPE 9 INHIBITORS IN PATIENTS BASED ON A REAL-WORLD DATA ANALYSIS IN USA

Full Text

PDG62 CURRENT TREATMENT STATUS WITH PROPROTEIN CONVERTASE SUBTILISIN-KEXIN TYPE 9 INHIBITORS IN PATIENTS BASED ON A REAL-WORLD DATA ANALYSIS IN USA

Abstract

Authors

A. Igarashi T. Takeshima K. Iwasaki

Back to Volume 22, Supplemental S2

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now